Search Result "Hodgkin's disease"


Mini-Review Article

Recent Advances in Nanobiotechnology for the Treatment ofNon-Hodgkin’s Lymphoma

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 24 Issue: 9 Year: 2024 Page: 895-907
Author(s):

Hematological Neoplasia and Angiogenesis: A Review

Ebook: Physiopathogenesis of Hematological Cancer
Volume: 1 Year: 2012
Author(s): Estela Maria Novak
Doi: 10.2174/978160805259211201010122

Research Article

Nano Conjugated PLGA-Chlorambucil: Synthesis In Vitro Anti Non- Hodgkin's Lymphoma Cellular Assay

Journal: Letters in Drug Design & Discovery
Volume: 14 Issue: 7 Year: 2017 Page: 827-836
Author(s): Saeed Akbarian, Jafar Sojoodi, Fatemeh Monnavari, Hossein Heidari, Pegah Khosravian, Hamid A. Javar, Artin Assadi, Rahimeh Rasouli, Mostafa Saffari, Seyed A.S. Shandiz, Hadi Hejazinia, Farnoor D. Omoomi, Mohammad Saffari, Mehdi S. Ardestani

Case Report

Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a Patientwith Hodgkin's Lymphoma History from North of Iran

Journal: Infectious Disorders - Drug Targets
Volume: 21 Issue: 8 Year: 2021 Page: 12-15
Author(s): David Darvishnia,Mahdieh Sadeghi,Ali Sharifpour,Zakaria Zakariaei,Elham Sadat Banimostafavi,Mahdi Fakhar,Rabeeh Tabaripour

Diffuse Large B-Cell Lymphoma with Involvement of the Chest Wall

Journal: Current Respiratory Medicine Reviews
Volume: 9 Issue: 2 Year: 2013 Page: 75-78
Author(s): William H. Porr,Jonathan L. Henderson,Michael J. Morris

Review Article

Statins as the Controlling Agents for Non-Hodgkin's Lymphomas via Increasing the Casein Kinase 2 Interacting Protein-1: A Hypothesis

Journal: Current Drug Discovery Technologies
Volume: 17 Issue: 5 Year: 2020 Page: 616-618
Author(s): Kimia Kazemi,Negin Mozafari,Hajar Ashrafi,Pedram Rafiei,Amir Azadi

Research Article

Enhancement in Biological Activity of L-Asparginase by its Conjugation on Silica Nanoparticles

Journal: Recent Patents on Nanotechnology
Volume: 12 Issue: 1 Year: 2018 Page: 70-82
Author(s): Dorsa Golestaneh,Jaleh Varshosaz

Research Article

A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma

Journal: Current Topics in Medicinal Chemistry
Volume: 21 Issue: 9 Year: 2021 Page: 790-818
Author(s): Shahrukh Qureshi,Ravina Khandelwal,Maddala Madhavi,Naveesha Khurana,Neha Gupta,Saurav K. Choudhary,Revathy A. Suresh,Lima Hazarika,Chillamcherla D. Srija,Khushboo Sharma,Mali R. Hindala,Tajamul Hussain,Anuraj Nayarisseri,Sanjeev K. Singh

Review Article

CDK9 as an Appealing Target for Therapeutic Interventions

Journal: Current Drug Targets
Volume: 20 Issue: 4 Year: 2019 Page: 453-464
Author(s): Shirin Eyvazi,Mohammad Saeid Hejazi,Homan Kahroba,Mozghan Abasi,Reza Eghdam Zamiri,Vahideh Tarhriz

Research Article open access plus

Discovery of Structural Prospects of Imidazo[1,5-a]pyrazine Derivatives as BTK Inhibitors Against Cancer: A Computational Study

Journal: Letters in Drug Design & Discovery
Volume: 18 Issue: 12 Year: 2021 Page: 1165-1177
Author(s): Amena Ali,Abuzer Ali,Mohamed Jawed Ahsan

Previous   Next

Go To   Results 1 - 1 of 19

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy